Stocktoria
Nutex Health Inc. NUTX
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2011-03-18
Nutex Health Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% |
| FCF margin | 28.1% | 4.3% | -3.3% | 16.4% | 41.2% |
| Return on assets | 7.7% | 7.9% | -11.5% | -98.4% | 33.6% |
| Return on equity | 16.7% | 27.6% | -57.9% | -353.0% | 69.2% |
| Debt / equity | 0.07× | 0.12× | 0.33× | 0.19× | 0.41× |
| Current ratio | 3.41 | 1.90 | 1.56 | 1.79 | 4.09 |
| Revenue growth | 82.4% | 93.8% | 12.9% | -33.9% | 21.0% |
Source: SEC EDGAR filings · CIK 0001479681 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.